Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
Date | Price Target | Rating | Analyst |
---|---|---|---|
12/24/2024 | Outperform → Mkt Perform | Keefe Bruyette | |
12/20/2024 | $16.00 | Mkt Perform → Strong Buy | Raymond James |
12/4/2024 | $12.00 → $14.50 | Mkt Perform → Outperform | Keefe Bruyette |
9/20/2023 | $10.75 | Outperform | Hovde Group |
9/12/2023 | $12.00 | Buy | Seaport Research Partners |
12/21/2022 | Mkt Perform | Raymond James | |
1/10/2022 | $18.00 | Mkt Perform | Keefe Bruyette |
7/8/2021 | Outperform → Mkt Perform | Raymond James |
Keefe Bruyette downgraded Brookline Bancorp from Outperform to Mkt Perform
Raymond James upgraded Brookline Bancorp from Mkt Perform to Strong Buy and set a new price target of $16.00
Keefe Bruyette upgraded Brookline Bancorp from Mkt Perform to Outperform and set a new price target of $14.50 from $12.00 previously
4 - BROOKLINE BANCORP INC (0001049782) (Issuer)
4 - BROOKLINE BANCORP INC (0001049782) (Issuer)
4 - BROOKLINE BANCORP INC (0001049782) (Issuer)
8-K - BROOKLINE BANCORP INC (0001049782) (Filer)
10-Q - BROOKLINE BANCORP INC (0001049782) (Filer)
8-K - BROOKLINE BANCORP INC (0001049782) (Filer)
4 - BROOKLINE BANCORP INC (0001049782) (Issuer)
4 - BROOKLINE BANCORP INC (0001049782) (Issuer)
4 - BROOKLINE BANCORP INC (0001049782) (Issuer)
NEW YORK, Aug. 26, 2025 /PRNewswire/ -- Elanco Animal Health Inc. (NYSE:ELAN) will replace Sarepta Therapeutics Inc. (NASD: SRPT) in the S&P MidCap 400, and Sarepta Therapeutics will replace Brookline Bancorp Inc. (NASD: BRKL) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, September 2. S&P SmallCap 600 constituent Berkshire Hills Bancorp Inc. (NYSE:BHLB) is acquiring Brookline Bancorp in a deal expected to be completed soon, pending final closing conditions. Post merger, Berkshire Hills Bancorp will remain in the S&P SmallCap 600 with a name and ticker change to Beacon Financial Corp. (NYSE:BBT). Following is a summary of the changes that will take place prior
All required regulatory approvals related to the proposed merger have been received.Proposed merger closing is expected to be completed effective September 1, 2025, subject to the satisfaction of the remaining customary closing conditions.Clients will continue to be served through their respective Berkshire Bank, Brookline Bank, Bank Rhode Island and PCSB Bank offices as divisions of Beacon Bank & Trust until systems conversion in 2026. BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Berkshire Hills Bancorp, Inc. ("Berkshire") (NYSE:BHLB), the parent company of Berkshire Bank, and Brookline Bancorp, Inc. ("Brookline") (NASDAQ:BRKL), the parent company of Brookline Bank, Bank Rhode Island, and P
All required regulatory approvals related to the proposed merger have been received.Proposed merger closing is expected to be completed effective September 1, 2025, subject to the satisfaction of the remaining customary closing conditions.Clients will continue to be served through their respective Berkshire Bank, Brookline Bank, Bank Rhode Island and PCSB Bank offices as divisions of Beacon Bank & Trust until systems conversion in 2026.BOSTON, Aug. 25, 2025 /PRNewswire/ -- Berkshire Hills Bancorp, Inc. ("Berkshire") (NYSE:BHLB), the parent company of Berkshire Bank, and Brookline Bancorp, Inc. ("Brookline") (NASDAQ:BRKL), the parent company of Brookline Bank, Bank Rhode Island, and PCSB Bank
NEW YORK, Aug. 26, 2025 /PRNewswire/ -- Elanco Animal Health Inc. (NYSE:ELAN) will replace Sarepta Therapeutics Inc. (NASD: SRPT) in the S&P MidCap 400, and Sarepta Therapeutics will replace Brookline Bancorp Inc. (NASD: BRKL) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, September 2. S&P SmallCap 600 constituent Berkshire Hills Bancorp Inc. (NYSE:BHLB) is acquiring Brookline Bancorp in a deal expected to be completed soon, pending final closing conditions. Post merger, Berkshire Hills Bancorp will remain in the S&P SmallCap 600 with a name and ticker change to Beacon Financial Corp. (NYSE:BBT). Following is a summary of the changes that will take place prior
BOSTON, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Brookline Bancorp, Inc. (NASDAQ:BRKL) ("Brookline"), today announced that it has completed its acquisition of PCSB Financial Corporation (NASDAQ:PCSB) ("PCSB"), a $1.9 billion bank holding company based in Yorktown Heights, New York, effective January 1, 2023. PCSB's bank subsidiary, PCSB Bank, now operates as a separate subsidiary of Brookline Bancorp and has 15 banking offices throughout the Lower Hudson Valley of New York State. Michael P. Goldrick assumed the role of President and CEO of PCSB Bank on January 1st. Prior to his appointment as President and CEO, Mr. Goldrick served as PCSB Bank's Executive Vice President and Chief Lending Officer
Mark Meiklejohn Will Become Chief Credit Officer of Brookline Bancorp, Inc. William Tsonos to Become President and CEO of Bank Rhode Island BOSTON, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Brookline Bancorp (NASDAQ:BRKL) Chairman & CEO Paul Perrault announced today three key changes affecting leadership positions at Brookline Bancorp, Inc. (the "Company") and Bank Rhode Island, its Rhode Island subsidiary bank. After thirteen years as the Company's Chief Credit Officer, M. Robert Rose will retire effective November 1st. Rose will remain with the Company as an executive officer and assume a leadership position with the Company's board and management credit committees. "Bob's long and success
Net Income of $22.0 million, EPS of $0.25 Quarterly Dividend of $0.135 BOSTON, July 23, 2025 (GLOBE NEWSWIRE) -- Brookline Bancorp, Inc. (NASDAQ:BRKL) (the "Company") today announced net income of $22.0 million, or $0.25 per basic and diluted share, for the second quarter of 2025, compared to net income of $19.1 million, or $0.21 per basic and diluted share, for the first quarter of 2025, and $16.4 million, or $0.18 per basic and diluted share, for the second quarter of 2024. The Company reported operating earnings after tax (non-GAAP) of $22.4 million, or $0.25 per basic and diluted share, for the second quarter of 2025, compared to operating earnings after tax (non-GAAP) of $20.0 mil
BOSTON, July 07, 2025 (GLOBE NEWSWIRE) -- Brookline Bancorp, Inc. (NASDAQ:BRKL) announced today that it will report second quarter 2025 earnings at the close of business on Wednesday, July 23, 2025. Management will host a conference call to review this information at 1:30 PM Eastern Time on Thursday, July 24, 2025. Interested parties may listen to the call and view a copy of the Company's Earnings Presentation by joining the call via https://events.q4inc.com/attendee/149362707. To listen to the call without access to the slides, interested parties may dial 833-470-1428 (United States) or 404-975-4839 (internationally) and ask for the Brookline Bancorp conference call (Access Code 673409).
Net Income of $19.1 million, EPS of $0.21 Operating Earnings of $20.0 million, Operating EPS of $0.22 Quarterly Dividend of $0.135 BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Brookline Bancorp, Inc. (NASDAQ:BRKL) (the "Company") today announced net income of $19.1 million, or $0.21 per basic and diluted share, for the first quarter of 2025, compared to net income of $17.5 million, or $0.20 per basic and diluted share, for the fourth quarter of 2024, and $14.7 million, or $0.16 per basic and diluted share, for the first quarter of 2024. The Company reported operating earnings after tax (non-GAAP) of $20.0 million, or $0.22 per basic and diluted share, for the first quarter of 2025, compar
SC 13G/A - BROOKLINE BANCORP INC (0001049782) (Subject)
SC 13G/A - BROOKLINE BANCORP INC (0001049782) (Subject)
SC 13G/A - BROOKLINE BANCORP INC (0001049782) (Subject)